Neuroimaging can identify potentially reversible structural disorders (eg, normal-pressure hydrocephalus, brain tumors, subdural hematoma) and certain metabolic disorders (eg, pantothenate kinase-associated neurodegeneration [formerly known as Hallervorden-Spatz disease], Wilson disease) and irreversible disorders (eg, stroke, leukodystrophy, Creutzfeld-Jacob disease).